UroGen Pharma Ltd. Public Float
UroGen Pharma Ltd. (URGN) had Public Float of $620.40 million as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $620.40M.
- 2024-06-28: Entity Public Float $675.10M.
- 2023-06-30: Entity Public Float $190.40M.
- 2022-06-30: Entity Public Float $145.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $620.40M 10-K · filed 2026-03-02 |
| 2024-06-28 | $675.10M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $190.40M 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $145.10M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $250.60M 10-K · filed 2022-03-21 |
| 2020-06-30 | $525.40M 10-K · filed 2021-03-18 |
| 2019-06-28 | $695.30M 10-K · filed 2020-03-02 |
| 2018-06-30 | $719.50M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |